Astellas Pharma and AstraZeneca are joining Bristol Myers Squibb by partnering with Evinova and using its AI platform designed to speed up clinical development.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Astellas Pharma and AstraZeneca are joining Bristol Myers Squibb by partnering with Evinova and using its AI platform designed to speed up clinical development.